DR. MATTHEW DANIEL LIPPAS M.D.
NPI 1790770717
Ophthalmology in Dallas, TX

Active since September 15, 2005PECOS EnrolledAccepts Medicare Assignment
91.38/100
CMS Quality Rating
8144 WALNUT HILL LN, SUITE 448, DALLAS, TX 75231(214) 369-3433(214) 369-0636 Get Directions Write a Review

NPPES record last updated: July 8, 2007. Verified against the NPPES registry weekly; last sync: August 02, 2026.

About Dr. Matthew Daniel Lippas M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. MATTHEW DANIEL LIPPAS M.D. (NPI 1790770717) is an individual ophthalmology provider in Dallas, Texas, licensed in Texas (G6740) and active in the NPI registry since September 2005. He is enrolled in Medicare PECOS and is a graduate of University Of Texas Medical School At Houston (1983).

NPPES Registry Identity

NPI1790770717
Entity TypeIndividualMale
Primary Taxonomy207W00000X
Provider Legal NameDR. MATTHEW DANIEL LIPPASCredential: M.D.
Location Address8144 WALNUT HILL LN, SUITE 448Dallas, TX 75231-4388
Mailing Address8144 Walnut Hill Ln, Suite 448Dallas, TX 75231-4388 · (214) 369-3433 · Fax (214) 369-0636
Fax(214) 369-0636
Sole ProprietorYes
Medical School CMSUniversity Of Texas Medical School At HoustonGraduated 1983
Enumeration DateSeptember 15, 2005
Last NPPES UpdateJuly 8, 2007
NPI 1790770717 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyOphthalmologyAllopathic & Osteopathic Physicians
Taxonomy Code207W00000X
License Licensed in TX · G6740
Definition
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
8144 WALNUT HILL LN, Dallas, TX 75231

Other Identifiers 2

Medicare UPINC18457TX
Medicare ID-Type Unspecified0010AYTX

Accepted Insurance

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Matthew Daniel Lippas M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID8729274931
PECOS Enrollment IDI20101202000380
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 12

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, faricimab-svoa, 0.1 mg J2777
Faricimab-svoa is a medication given through an injection into the eye to treat certain eye conditions. The 0.1 mg dosage helps control disease progression, improving vision and eye health. The procedure is done by a healthcare professional.
7,320 services25 patients
Established patient complete exam of visual system 92014
An established patient complete exam of the visual system involves a thorough check of your eyes and vision. It assesses eye health, checks for diseases, and measures your ability to see clearly at different distances. It's a routine, non-invasive procedure.
616 services270 patients
Imaging of retina 92134
Imaging of the retina is a non-invasive procedure that captures detailed images of your eye's interior. This helps detect conditions like macular degeneration or retinal detachment. It's painless and takes only a few minutes.
614 services215 patients
Injection of drug into eye 67028
An injection into the eye is a procedure where a medication is delivered directly into your eye to treat various conditions. A local anesthetic is applied to numb the eye, ensuring minimal discomfort. The drug helps manage diseases like macular degeneration or diabetic retinopathy.
423 services80 patients
Injection, bevacizumab, 10 mg J9035
Bevacizumab is a medication given through an injection. It's designed to prevent the growth of new blood vessels that cancer cells need to grow and spread. The 10 mg dose refers to the amount of the drug in the injection.
192 services54 patients
Injection, aflibercept, 1 mg J0178
Aflibercept injection is a treatment for certain eye conditions that affect vision. It works by blocking abnormal blood vessel growth and leakage in the eye, which can cause vision loss. The medication is administered directly into the eye by a healthcare professional.
114 services19 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 75231 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$131.01 typical visit price
range $57.18 – $172.86
Typical copayment $32.75 (range $14.29 – $43.21)
Most-billed visit code 99204
Established Patient
$71.28 typical visit price
range $18.48 – $141.20
Typical copayment $17.82 (range $4.62 – $35.30)
Most-billed visit code 99213
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

91.38/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Quality100
Improvement Activities40
Cost71.27

Reported Quality Measures

Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement
Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) or their caregiver(s) who were counseled within 12 months on the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formulation for…
97%194 patients4/55-star benchmark: 100%
Age-Related Macular Degeneration (AMD): Dilated Macular Examination
Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or geographic atrophy or…
95%194 patients4/55-star benchmark: 100%
Diabetes: Eye Exam
Percentage of patients 18-75 years of age with diabetes who had a retinal or dilated eye exam by an eye care professional during the measurement period or a negative retinal exam (no evidence of retinopathy) in the 12 months prior to the measurement period
97%295 patients4/55-star benchmark: 100%
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus…
81%163 patients3/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
88%136 patients4/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
90%493 patients4/55-star benchmark: 100%
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) who have an optic nerve head evaluation during one or more office visits within 12 months
100%120 patients5/55-star benchmark: 100%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
90%493 patients4/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 20

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Physical Therapist (Hand)
8144 WALNUT HILL LN, STE 100
DALLAS, TX 75231
Dermatology
8144 WALNUT HILL LN, STE 360
DALLAS, TX 75231
Specialist
8144 WALNUT HILL LN, SUITE 800
DALLAS, TX 75231
Physical Therapist
8144 WALNUT HILL LN, SUITE 100
DALLAS, TX 75231
Internal Medicine (Rheumatology)
8144 WALNUT HILL LN, SUITE 800
DALLAS, TX 75231
Internal Medicine (Rheumatology)
8144 WALNUT HILL LN, SUITE 800
DALLAS, TX 75231
Physical Therapist
8144 WALNUT HILL LN, STE 100
DALLAS, TX 75231
Otolaryngology
8144 WALNUT HILL LN, #170
DALLAS, TX 75231

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Matthew Lippas's NPI number?

The NPI number for Matthew Lippas is 1790770717. It was assigned to this individual provider in the NPPES registry on September 15, 2005.

Where is Matthew Lippas located?

Matthew Lippas practices at 8144 Walnut Hill Ln Suite 448, Dallas, TX 75231. The listed phone number is (214) 369-3433.

What is Matthew Lippas's specialty?

The primary specialty registered for this NPI is Ophthalmology with taxonomy code 207W00000X.

Is Matthew Lippas enrolled in Medicare?

Yes. Matthew Lippas is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

What insurance does Matthew Lippas accept?

Health plans from Baylor Scott and White Health Plan list Matthew Lippas as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for Matthew Lippas was last updated on July 8, 2007. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 19 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.